LU83556A1 - Nouvelles compositions pharmaceutiques contenant de l'almitrine - Google Patents

Nouvelles compositions pharmaceutiques contenant de l'almitrine Download PDF

Info

Publication number
LU83556A1
LU83556A1 LU83556A LU83556A LU83556A1 LU 83556 A1 LU83556 A1 LU 83556A1 LU 83556 A LU83556 A LU 83556A LU 83556 A LU83556 A LU 83556A LU 83556 A1 LU83556 A1 LU 83556A1
Authority
LU
Luxembourg
Prior art keywords
almitrine
doses
respiratory
ventilation
blood
Prior art date
Application number
LU83556A
Other languages
English (en)
French (fr)
Inventor
Etienne Labeyrie
Jean P Poirier
Francoise Arnaud
Original Assignee
Science Union & Cie
Medicale Rech France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie, Medicale Rech France filed Critical Science Union & Cie
Publication of LU83556A1 publication Critical patent/LU83556A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU83556A 1980-08-18 1981-08-14 Nouvelles compositions pharmaceutiques contenant de l'almitrine LU83556A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8018074 1980-08-18
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Publications (1)

Publication Number Publication Date
LU83556A1 true LU83556A1 (fr) 1982-04-14

Family

ID=9245242

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83556A LU83556A1 (fr) 1980-08-18 1981-08-14 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Country Status (14)

Country Link
US (1) US4364946A (de)
AU (1) AU550741B2 (de)
BE (1) BE890011A (de)
CA (1) CA1181694A (de)
CH (1) CH650152A5 (de)
DE (1) DE3132654A1 (de)
FR (1) FR2488509A1 (de)
GB (1) GB2082064B (de)
GR (1) GR75328B (de)
IE (1) IE52095B1 (de)
IT (1) IT1171461B (de)
LU (1) LU83556A1 (de)
NZ (1) NZ198062A (de)
ZA (1) ZA815664B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
ES2688229T3 (es) * 2009-07-31 2018-10-31 Mts Systems Corporation Montaje de ensayo del tren de accionamiento de una turbina eólica
WO2018134265A1 (en) 2017-01-17 2018-07-26 Forrest Michael David Therapeutic inhibitors of the reverse mode of atp synthase
WO2019012149A1 (en) * 2017-07-13 2019-01-17 Forrest Michael David THERAPEUTIC MODULATORS OF THE INVERSE MODE OF ATP SYNTHASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256513A (de) * 1968-10-02 1971-12-08

Also Published As

Publication number Publication date
ZA815664B (en) 1982-08-25
GR75328B (de) 1984-07-13
US4364946A (en) 1982-12-21
IT8149104A1 (it) 1983-02-13
CH650152A5 (fr) 1985-07-15
FR2488509A1 (fr) 1982-02-19
IE52095B1 (en) 1987-06-10
BE890011A (fr) 1982-02-18
FR2488509B1 (de) 1984-11-23
DE3132654A1 (de) 1982-06-24
CA1181694A (fr) 1985-01-29
GB2082064B (en) 1985-06-26
IT8149104A0 (it) 1981-08-13
AU7427781A (en) 1982-02-25
GB2082064A (en) 1982-03-03
AU550741B2 (en) 1986-04-10
IE811891L (en) 1982-02-18
IT1171461B (it) 1987-06-10
NZ198062A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
Clark et al. Sleep apnea: treatment with protriptyline
EP0440704B1 (de) Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak
Kannel et al. Atherosclerosis as a pediatric problem
Wang et al. Glucose metabolism in pig outer retina in light and darkness
Kryger et al. The sleep deprivation syndrome of the obese patient: a problem of periodic nocturnal upper airway obstruction
Turhanoğlu et al. Effects of different doses of oral ketamine for premedication of children
Carrive et al. Orexin and central modulation of cardiovascular and respiratory function
JP5902148B2 (ja) 自閉症治療用ジメチルスルホキシド（ｄｍｓｏ）製剤
Reeves et al. Early postnatal chronic intermittent hypoxia modifies hypoxic respiratory responses and long-term phrenic facilitation in adult rats
US20140271890A1 (en) Controlled-release pharmaceutical composition
González-Duarte et al. Familial dysautonomia
US6436946B1 (en) Xanthine-containing compositions for oral administration and uses related thereto
LU83556A1 (fr) Nouvelles compositions pharmaceutiques contenant de l'almitrine
Alipour et al. Comparison of tadalafil and sildenafil in controlling neonatal persistent pulmonary hypertension
FR2765107A1 (fr) Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
US20200155553A1 (en) Arterial Oxygen Saturation Degree Improver
WO2005002602A2 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
EP1767200A1 (de) Mittel gegen hautalterung
KR100740079B1 (ko) 당뇨병성 신경 장해용 의약 조성물
Sharma et al. Comparison of Magnesium Pre-treatment With Two Different Doses of Rocuronium in Rapid Sequence Intubation: A Randomized Controlled Trial
Rosenzweig et al. Neurobiology and physiology of sleep and breathing
US20200085849A1 (en) Methods and compositions for improving sleep
KAFER et al. Respiratory and cardiovascular responses to hypoxemia and the effects of anesthesia
TW201642848A (zh) 用於治療運動病症之組合物及方法
Aschner New therapies for pulmonary hypertension in neonates and children